EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Serum Complement C3 and C4 Levels in Patients with Type 2 Diabetes Mellitus in Al-Najaf Province, Iraq: A Case-Control Study

Eman Th. Nadhaif Al-Fatlawy

Medical Science Journal for Advance Research · 01.09.2026 · 7 (3)

DOI: 10.46966/msjar.v7i3.453 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Medical Science Journal for Advance Research, online erschienen am 01.09.2026. Verfasst von Eman Th. Nadhaif Al-Fatlawy. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) is an abnormal long-term metabolic condition in which people have high blood-sugar levels, low-grade inflammation, and abnormal immune system activity. The complement system, namely, complement components C3 and C4, might be potentially involved in metabolic inflammation and insulin resistance. Random blood sugar (RBS) and glycemic parameters levels may also give some clues about changes in inflammation and metabolism in these patients with T2DM.

Objective

To compare the levels of complement C3, complement C4, C-reactive protein (CRP), and RBC level between patients with T2DM and apparently healthy subjects in Al-Najaf Province, Iraq and investigate association between these biomarkers.

Methods

A case-control study was conducted at the Diabetes Unit, Al-Sadr Teaching Hospital, Al-Najaf, Iraq, from October 2024 to April 2025. The study enrolled 35 patients with T2DM and 30 apparently healthy controls. Demographic data, including age and sex, were recorded. Serum C3, C4, CRP, and RBS levels were measured and compared between groups. Spearman’s correlation analysis, multivariable logistic regression, and receiver operating characteristic (ROC) curve analysis were performed. A p-value of < 0.05 was considered statistically significant.

Results

Patients with T2DM were significantly older than controls (54.43±11.62 vs. 36.03±2.82 years; p

Zitieren

APA

Al-Fatlawy, E. T. N. (2026). Serum Complement C3 and C4 Levels in Patients with Type 2 Diabetes Mellitus in Al-Najaf Province, Iraq: A Case-Control Study. Medical Science Journal for Advance Research, 7(3). https://doi.org/10.46966/msjar.v7i3.453

Vancouver

Al-Fatlawy ETN. Serum Complement C3 and C4 Levels in Patients with Type 2 Diabetes Mellitus in Al-Najaf Province, Iraq: A Case-Control Study. Medical Science Journal for Advance Research. 2026;7(3). doi:10.46966/msjar.v7i3.453

BibTeX
@article{AlFatlawy2026,
  author = {Al-Fatlawy, Eman Th. Nadhaif},
  title = {Serum Complement C3 and C4 Levels in Patients with Type 2 Diabetes Mellitus in Al-Najaf Province, Iraq: A Case-Control Study},
  journal = {Medical Science Journal for Advance Research},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.46966/msjar.v7i3.453}
}
Kostenlos starten →